Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit
NCT ID: NCT01299025
Last Updated: 2015-04-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2010-09-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
People with diagnosed multiple sclerosis are invited to participate. Estimation of study power gave that 29 people in each group was necessary to detect a difference in the primary outcome measure, Timed Up and Go test.
Other measures used are the Four square step test, Dynamic Gait Index, Timed stands test, 25 foot walking test, 12-item Walking scale and the ABC scale.
Participants were randomised to either training or control. The training consisted of 6 weeks training with Nintendo Wii Fit 30 minutes 2 times a week.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects
NCT02287948
Group Balance Training for People With Multiple Sclerosis
NCT01582126
How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis?
NCT02870023
Evaluation of a Self-management Program to Prevent Falls in People With Multiple Sclerosis
NCT05789225
Balance Training in Parkinson's Disease Using the Wii Balance Board
NCT01228851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants allocated as controls receive no treatment. They may be physically active as usual.
No interventions assigned to this group
Training with Nintendo Wii Fit
Training 6 weeks with Nintendo Wii Fit, 30 minutes 2 times per week
Training using Nintendo Wii Fit
Training 2 times per week, 30 minutes, for 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training using Nintendo Wii Fit
Training 2 times per week, 30 minutes, for 6 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjective experience of affected balance and walking
* Being able to walk 100 meters with assistance
Exclusion Criteria
* Visual deficits that prevents training with television games
* Weight above 149 kg
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala-Örebro Regional Research Council
OTHER
Norrbacka-Eugenia Foundation
OTHER
Örebro County Council
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anette Forsberg, PhD
PhD, Research physical therapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anette Forsberg, PhD
Role: PRINCIPAL_INVESTIGATOR
Örebro County Council
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mälarsjukhuset
Eskilstuna, , Sweden
Karlstad hospital
Karlstad, , Sweden
Family Medicine Research centre
Örebro, , Sweden
Västerås hospital
Västerås, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ö28-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.